查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1739179

全球醫用同位素市場

Medical Isotopes
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 266 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球醫用同位素市場規模將達88億美元

全球醫用同位素市場規模預計在2024年為59億美元，預計到2030年將達到88億美元，2024年至2030年的複合年成長率為6.9%。穩定同位素是本報告分析的細分市場之一，預計其複合年成長率為5.5%，到分析期結束時將達到49億美元。放射性同位素細分市場在分析期間內的複合年成長率預計為9.1%。

美國市場規模估計為 16 億美元，中國市場預期複合年成長率為 10.6%

美國醫用同位素市場規模預計在2024年達到16億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到18億美元，在2024-2030年的分析期間內，複合年成長率為10.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為3.6%和6.7%。在歐洲，預計德國的複合年成長率為4.5%。

全球醫用同位素市場—主要趨勢與促進因素摘要

為什麼醫用同位素對於診斷影像和標靶治療至關重要？

醫用同位素在現代醫療保健中至關重要，因為它們應用廣泛，包括診斷成像、標靶放射治療和疾病監測。這些同位素——具有特定半衰期的放射性原子——在核醫學程序中用作示蹤劑，用於觀察器官功能、檢測腫瘤、評估代謝活動和監測治療結果。Technetium-99m (Tc-99m)、氟-18 (F-18)、碘-131 (I-131) 和鎦-177 (Lu-177) 等主要同位素廣泛應用於 SPECT、PET 和放射治療方案。

隨著癌症、心血管疾病和神經系統疾病的發生率不斷上升，核醫學影像的需求也日益成長，而醫用同位素是精準診斷的核心。與傳統的解剖結構成像不同，同位素掃描能夠即時提供生理和生化訊息，從而實現更早的發現、更準確的疾病分期和個人化治療方案。隨著醫療保健產業將重點轉向基於價值的護理和個人化醫療，醫用同位素正逐漸成為數據豐富、微創診斷和治療解決方案的關鍵推動因素。

生產技術和供應鏈模式如何發展以滿足市場需求？

為滿足日益成長的全球需求並解決長期存在的供應漏洞，醫用同位素生產正在經歷重大變革時期。傳統上，同位素生產依賴於使用高濃縮鈾 (HEU) 的老化核子反應爐，如今正轉向使用低濃縮鈾 (LEU) 靶和非核子反應爐替代方案，例如迴旋加速器、線性加速器和基於發電機的系統。這項轉變的推動因素包括安全擔憂以及減少武器級核子材料在民用應用中使用的監管壓力。

基於迴旋加速器的生產，尤其是對於F-18等短壽命同位素的生產，因其能夠最大限度地減少運輸過程中的放射性崩壞並服務於局部醫療保健網路而日益受到青睞。基於發生器的解決方案，例如鉬-99/Technetium-99m（Mo-99/Tc-99m）系統，可以實現現場同位素提取，從而減少對集中式供應鏈的依賴。各國政府和私人相關人員相關者正在投資支持同位素供應彈性的基礎設施，包括備用反應器、區域迴旋加速器網路和放射性藥物生產設施。隨著這些發展，關鍵同位素的供應途徑正變得更加穩定、多樣化和可擴展。

哪些臨床領域和手術量正在推動全球同位素的使用？

醫用同位素需求最高的領域是腫瘤科、心臟科和神經科。在腫瘤科，同位素既用於診斷（例如，使用F-18 FDG進行PET顯像以識別腫瘤和轉移病灶），也用於治療（例如，使用I-131顯像治療甲狀腺癌，使用Lu-177顯像治療前列腺癌）。核子醫學影像使腫瘤學家能夠比形態學成像技術更早評估腫瘤代謝和治療反應。同樣，使用Tc-99m甲氧基異丁基異腈進行心臟壓力測試有助於檢測冠狀動脈疾病和心肌灌注障礙，從而對心血管疾病的管理做出重大貢獻。

神經系統應用日益受到關注，尤其是在阿茲海默症、帕金森氏症和癲癇的早期發現方面。使用F-18或碳基同位素的PET成像可用於繪製腦活動圖譜，並在出現身體症狀之前評估神經退化。在整形外科和內分泌科，同位素也有助於診斷骨轉移和甲狀腺功能障礙。隨著人口老化和非傳染性疾病在全球的流行，核子醫學檢查的數量正在增加，尤其是在門診影像中心、癌症醫院和學術研究機構。

什麼將推動醫用同位素市場的長期成長和創新？

醫用同位素市場的成長得益於診斷影像量的增加、標靶放射性核種治療的擴展、監管現代化以及放射性藥物研發的進步。將診斷和治療能力整合到單一同位素平台的治療診斷學日益普及，正在創造巨大的商業性和臨床機會。例如，镥-177和錒-225正在被開發用於轉移性癌症的成像和治療，從而實現更精準的治療匹配和即時療效追蹤。

美國能源部/國家核安局計劃和歐盟「地平線」計劃等全球官民合作關係正在資助下一代同位素生產技術和放射性藥物研發管線。此外，加拿大、印度、韓國和南非等國家正在擴大國內同位素生產，以減少對有限的全球供應商的依賴。新興市場核子醫學領域的擴張以及PET-CT和PET-MRI混合成像系統的整合，正在增強對同位素的需求。

同時，跨市場監管協調和藥典標準的更新正在簡化新型放射性示蹤劑和標記試劑套件的核准途徑。隨著精準醫療和分子診斷技術的不斷發展，醫用同位素的戰略作用將進一步深化，使其成為全球高性能、個人化醫療基礎設施的基石。

部分

類型（穩定同位素、放射性同位素）；最終用戶（醫院、診斷中心、研究機構）

受訪公司範例（值得關注的32家公司）

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health（Nordion）
  • Theragnostics Ltd

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP34059

Global Medical Isotopes Market to Reach US$8.8 Billion by 2030

The global market for Medical Isotopes estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Stable Isotopes, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Radioisotopes segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 10.6% CAGR

The Medical Isotopes market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Medical Isotopes Market - Key Trends & Drivers Summarized

Why Are Medical Isotopes Central to Diagnostic Imaging and Targeted Therapeutics?

Medical isotopes have become indispensable to modern healthcare due to their wide-ranging applications in diagnostic imaging, targeted radiotherapy, and disease monitoring. These isotopes-radioactive atoms with specific half-lives-are used as tracers in nuclear medicine procedures to visualize organ function, detect tumors, assess metabolic activity, and monitor treatment efficacy. Key isotopes such as Technetium-99m (Tc-99m), Fluorine-18 (F-18), Iodine-131 (I-131), and Lutetium-177 (Lu-177) are widely deployed in SPECT, PET, and radiotherapeutic protocols.

With the growing incidence of cancer, cardiovascular disease, and neurological disorders, demand for nuclear imaging is increasing steadily, placing medical isotopes at the heart of precision diagnostics. Unlike traditional imaging, which reveals anatomical structure, isotopic scans provide physiological and biochemical information in real time-enabling early detection, more accurate staging, and personalized treatment plans. As the healthcare industry pivots toward value-based care and personalized medicine, medical isotopes are emerging as crucial enablers of data-rich, low-invasiveness diagnostic and therapeutic solutions.

How Are Production Technologies and Supply Chain Models Evolving to Meet Market Demand?

Medical isotope production is undergoing significant transformation to meet rising global demand and address longstanding supply vulnerabilities. Traditionally reliant on aging nuclear reactors using highly enriched uranium (HEU), isotope production is now shifting toward low enriched uranium (LEU) targets and non-reactor alternatives such as cyclotrons, linear accelerators, and generator-based systems. This transition is driven by both security concerns and regulatory pressure to reduce the use of weapons-grade nuclear materials in civilian applications.

Cyclotron-based production, particularly for short-lived isotopes like F-18, is gaining traction due to its ability to serve localized healthcare networks with minimal radioactive decay during transit. Generator-based solutions-such as molybdenum-99/technetium-99m (Mo-99/Tc-99m) systems-enable on-site isotope extraction, reducing dependency on centralized supply chains. Governments and private-sector stakeholders are investing in infrastructure to support isotope supply resilience, including backup reactors, regional cyclotron networks, and radiopharmaceutical manufacturing facilities. These developments are ensuring more stable, diversified, and scalable supply pathways for critical medical isotopes.

Which Clinical Fields and Procedural Volumes Are Driving Isotope Utilization Globally?

The highest demand for medical isotopes originates from oncology, cardiology, and neurology segments. In oncology, isotopes are used in both diagnostics (e.g., PET imaging with F-18 FDG to identify tumors and metastases) and therapeutics (e.g., I-131 for thyroid cancer or Lu-177 for prostate cancer). Nuclear imaging enables oncologists to assess tumor metabolism and treatment response earlier than morphological imaging techniques. Similarly, cardiac stress tests using Tc-99m sestamibi help detect coronary artery disease and myocardial perfusion deficits, contributing significantly to cardiovascular disease management.

Neurological applications are gaining prominence, especially for early detection of Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET imaging with F-18 or carbon-based isotopes is used to map brain activity and evaluate neurodegeneration before physical symptoms manifest. In orthopedics and endocrinology, isotopes also help diagnose bone metastases and thyroid dysfunction. As population aging intensifies and non-communicable diseases become more prevalent globally, procedural volumes for nuclear medicine are rising-particularly in outpatient imaging centers, specialty cancer hospitals, and academic research institutions.

What Is Driving Long-Term Growth and Innovation in the Medical Isotopes Market?

The growth in the medical isotopes market is driven by rising diagnostic imaging volumes, expansion of targeted radionuclide therapy, regulatory modernization, and advancements in radiopharmaceutical R&D. The increasing adoption of theranostics-combining diagnostic and therapeutic capabilities into a single isotope platform-is creating significant commercial and clinical opportunities. For instance, Lu-177 and Actinium-225 are being developed to both image and treat metastatic cancer, allowing for better treatment matching and real-time response tracking.

Global public-private partnerships, such as the U.S. DOE/NNSA initiatives and EU Horizon projects, are funding next-generation isotope production technologies and radiopharmaceutical pipelines. Additionally, countries like Canada, India, South Korea, and South Africa are scaling up domestic isotope production to reduce dependence on limited global suppliers. The expansion of nuclear medicine departments in emerging markets and the integration of PET-CT and PET-MRI hybrid imaging systems are reinforcing demand.

Meanwhile, regulatory harmonization across markets and updated pharmacopoeia standards are streamlining approval pathways for novel radiotracers and labeling kits. As precision medicine and molecular diagnostics continue to advance, the strategic role of medical isotopes will deepen-positioning them as a cornerstone of high-performance, personalized healthcare infrastructure globally.

SCOPE OF STUDY:

The report analyzes the Medical Isotopes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Stable Isotopes, Radioisotopes); End-User (Hospitals, Diagnostic Centers, Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ARTMS Inc.
  • Bayer AG
  • Bruce Power
  • BWXT Medical Ltd.
  • Cambridge Isotope Laboratories, Inc.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler
  • GE Healthcare
  • International Isotopes Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • NTP Radioisotopes SOC Ltd
  • Nusano, Inc.
  • Orano Med
  • SHINE Technologies
  • Sotera Health (Nordion)
  • Theragnostics Ltd

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Medical Isotopes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Nuclear Imaging in Oncology Propels Growth in Medical Isotope Applications
    • Expansion of PET and SPECT Imaging Throws the Spotlight on Short-Lived Radioisotope Production
    • Increased Use of Technetium-99m in Diagnostic Procedures Strengthens Global Market Demand
    • Growth in Targeted Alpha Therapy Accelerates Innovation in Therapeutic Isotope Development
    • Surge in Thyroid and Bone Cancer Cases Drives Use of Iodine-131 and Samarium-153
    • Focus on Cyclotron and Non-Reactor-Based Isotope Production Enhances Supply Chain Resilience
    • Government Support for Domestic Isotope Production Facilities Spurs Regional Capacity Expansion
    • Technological Advancements in Radiopharmaceutical Synthesis Boost Clinical Efficiency
    • Growing Need for Companion Diagnostics Fuels Demand for Theranostic Isotope Pairing
    • Increasing Use of Lutetium-177 in Prostate Cancer Treatment Expands Targeted Radiotherapy Applications
    • Shortage of Reactor-Based Supply Chains Throws the Spotlight on Decentralized Production Models
    • Rising Investment in Cold Kits and Generator-Based Distribution Strengthens Delivery Infrastructure
    • Regulatory Streamlining for Isotope Approvals Accelerates Time-to-Market for Novel Radiotracers
    • Integration of Isotopes in Personalized Medicine Supports Patient-Specific Diagnostic Pathways
    • Emergence of Actinium-225 and Other Alpha Emitters Creates Opportunities in Rare Cancer Treatment
    • Improved Logistics and Half-Life Optimization Techniques Drive Efficiency in Regional Supply Chains
    • Collaboration Between Research Institutions and Pharma Companies Expands Clinical Research Pipeline
    • Use of AI in Radiopharmaceutical Planning Enhances Patient Scheduling and Isotope Utilization
    • Expansion of Radiopharmacy Networks in Emerging Markets Supports Accessibility of Diagnostic Isotopes
    • Global Aging Population and Increased Cancer Screening Rates Sustain Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medical Isotopes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medical Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stable Isotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Stable Isotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Radioisotopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Radioisotopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Medical Isotopes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medical Isotopes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Medical Isotopes by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Medical Isotopes by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Medical Isotopes by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Medical Isotopes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Medical Isotopes by Type - Stable Isotopes and Radioisotopes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Medical Isotopes by Type - Stable Isotopes and Radioisotopes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Medical Isotopes by Type - Percentage Breakdown of Value Sales for Stable Isotopes and Radioisotopes for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Medical Isotopes by End-user - Hospitals, Diagnostic Centers and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Medical Isotopes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION